HLL Lifecare Limited, a Mini-Ratna Central Public Sector Enterprise (CPSE) under the Ministry of Health & Family Welfare, Government of India, has paid a record dividend of Rs. 69.53 crore to the Government of India for the financial year 2024–25. The dividend cheque was presented to Shri J.P. Nadda, Union Minister of Health & Family Welfare, by Dr. Anitha Thampi, Chairperson, HLL, in the presence of Smt. Anupriya Patel, Minister of State for Health & Family Welfare; Smt. Punya Salila Srivastava, Union Health Secretary; Shri Hovyeda Abbas, AS&FA; and Shri Vijay Nehra, Joint Secretary, Ministry of Health & Family Welfare. HLL's revenue from operations increased to Rs. 4,500 crore in FY 2024-25, reflecting a 20% growth over the previous year. The company's net worth rose significantly to Rs. 1,100 crore as on March 31, 2025. On a consolidated basis, including its subsidiaries — HITES, GAPL, and Lifespring Hospitals — the HLL Group recorded a total revenue of Rs. 4,900 crore, marking a 19% growth over the previous fiscal. The company continues to make essential medicines and surgical products affordable through AMRIT Pharmacies, saving more than Rs. 8000 Crores in terms of their out-of-pocket expenditure for over 6.7 crore people in the last 10 years. HLL was established on 1st March 1966.
Key Entities Referenced
HLL Lifecare Limited: A Mini-Ratna Central Public Sector Enterprise (CPSE) under the Ministry of Health & Family Welfare.
Ministry of Health & Family Welfare: The ministry under which HLL Lifecare Limited operates and to which the dividend is paid.
AMRIT Pharmacies: An initiative that provides affordable medicines, helping people save on healthcare expenditures.
Ministry of Health and Family Welfare
HLL pays Rs. 69.5 crores as dividend to
Government of India for Financial Year 2024-25
HLL is a reliable hand in the Medical Health Services: Shri
J.P. Nadda
HLL providing yeoman service towards Accessible,
Affordable and Quality healthcare: Union Health Minister
Posted On: 25 OCT 2025 5:31PM by PIB Delhi
HLL Lifecare Limited, a Mini-Ratna Central Public Sector Enterprise (CPSE) under the Ministry of
Health & Family Welfare, Government of India, has reinforced its strong financial performance by
paying a record dividend of Rs. 69.53 crore to the Government of India for the financial year 2024–
25. This is among the highest dividends ever paid by the company.
The dividend cheque was presented to Shri J.P. Nadda, Hon’ble Union Minister of Health & Family
Welfare, by Dr. Anitha Thampi, Chairperson, HLL, in the presence of Smt. Anupriya Patel, Minister
of State for Health & Family Welfare; Smt. Punya Salila Srivastava, Union Health Secretary; Shri
Hovyeda Abbas, AS&FA; and Shri Vijay Nehra, Joint Secretary, Ministry of Health & Family
Welfare. Senior officials from HLL, including Shri N. Ajit, Director (Marketing), and Shri Ramesh P,
Director (Finance), were also present.Speaking at the occasion, Shri J.P. Nadda asserted that, HLL is a reliable name in the field of Medical
Services and is committed towards the national vision of accessible, affordable and quality healthcare
to all.
Commending HLL’s performance, Shri J.P. Nadda, stated that, HLL along with its subsidiaries and
Amrit pharmacies have emerged as a key player in transforming the health sector. He highlighted that
in the last 10 years, over 6.7 crore people have benefited through the affordable medicines of the
Amrit Pharmacies, thereby saving more than Rs. 8000 Crores in terms of their out-of-pocket
expenditure.
The financial year 2024–25 witnessed comprehensive growth across both HLL’s manufacturing and
service portfolios. Revenue from operations increased to Rs. 4,500 crore, reflecting a 20% growth
over the previous year. The company’s net worth rose significantly to Rs. 1,100 crore as on March 31,
2025.On a consolidated basis, including its subsidiaries — HITES, GAPL, and Lifespring Hospitals — the
HLL Group recorded a total revenue of Rs. 4,900 crore, marking a 19% growth over the previous
fiscal.
Background
Established on 1st March 1966, HLL Lifecare Limited has evolved from addressing India’s
population control challenges to becoming a multi-product, multi-service healthcare enterprise
playing a pivotal role in the nation’s health sector transformation. Through initiatives such as AMRIT
Pharmacies, the company continues to make essential medicines and surgical products affordable,
thereby reducing out-of-pocket expenses for patients across the country.
As HLL celebrates its 60th year, it reaffirms its commitment for delivering quality healthcare
solutions, contributing to accessible, affordable, and equitable healthcare for all.
*****
SR
HFW-HFM HLL/25th Oct 2025/2
(Release ID: 2182460) Visitor Counter : 1057
Read this release in: Malayalam , Urdu , ही , Tamil